Advanced search×

Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery.

J Vasc Surg 54(3):779-84 (2011) PMID 21571492

Persistent variation in practice surrounds preoperative clopidogrel management at the time of vascular surgery. While some surgeons preferentially discontinue clopidogrel citing a perceived risk of perioperative bleeding, others will proceed with surgery in patients taking clopidogrel for an appropriate indication. The purpose of this study was to determine whether preoperative clopidogrel use was associated with significant bleeding complications during peripheral arterial surgery.

Copyright © 2011 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.jvs.2011.03.003
Version: za2963e q8zab q8zb7 q8zc7 q8zdb q8ze4 q8zf1 q8zg9

Similar articles you may find interesting…

  1. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cros...

    BMC Health Serv Res 13(1):170 (2013) PMID 23647871

    BACKGROUND: To promote rational drug use in developing countries, it is important to assess drug use pattern using the World Health Organization (WHO) drug use indicators. The aim of this study was to assess the drug prescription patterns at the Medical Outpatient Pharmacy of Hawassa...
  2. The role of potential mediators in racial inequalities in tooth loss: the Pró-Saúde study.

    Community Dent Oral Epidemiol (2013) PMID 23647615

    There is an association between race and tooth loss that is mainly explained by current and early life socioeconomic variables, but not by behavioural factors and self-reported discrimination. © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd....
  3. Hydrophobic gentamicin loaded nanoparticles are effective in Brucella melitensis in mice.

    Antimicrob Agents Chemother (2013) PMID 23650167

    These results strongly suggest that PLGA nanoparticles containing chemically modified hydrophobic gentamicin may be a promising alternative for the treatment of human brucellosis....